GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. On December 10, HSBC analyst ...
In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn’t tell us how to properly use them. I’d ...
Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...
In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary ...
Trials of a new asthma drug show that it could prove life changing for many people – who would only need two jabs a year. The ...
The injectable therapy contain antibodies that dampen inflammation in the lungs and is set to revolutionise the way severe ...
Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...
An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...
A 19-year-old in Lucknow received financial support from a Reddit user to buy asthma medication after sharing his struggles ...
Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...
The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...
Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback